Northwestern Medicine scientists have revealed how a gene considered essential for histone modification regulates skin development, according to a recent study published in Nature Communications.
Menu
Browsing: Cancer
Electronic health record-based messages delivered solely to clinicians increased referral to tobacco use treatment for cancer patients who smoke, according to a recent study published in the Journal of Clinical Oncology.
Northwestern Medicine investigators have identified new molecular details regarding how white blood cells move across the walls of microvessels during inflammation, revealing new potential molecular targets for treating the condition, according to a new study published in the journal Immunity.
Brian Lee, a second-year student in the Medical Scientist Training Program (MSTP), was the lead author of a study that found that a new combination therapy regimen improved survival in patients with B-cell lymphoma by 30 percent.
Combining immunotherapy with a tumor-targeted virus may help extend survival in some patients with recurrent glioblastoma, according to the results of a trial published in Nature Medicine.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University has received a renewed five-year $10.8 million Specialized Program of Research Excellence (SPORE) grant from the National Cancer Institute for the Lurie Cancer Center to advance translational research and improve outcomes for patients with brain cancer.
Northwestern Medicine investigators led by Ruli Gao, PhD, have developed a novel genetic sequencing tool that accelerates sequencing analysis of same-cell genotypes and phenotypes in tumors, as detailed in a study published in Nature Communications.
Northwestern Medicine scientists have developed a new cellular model of uterine fibroids that stem from a common genetic mutation, which will accelerate further research and treatment development, according to findings published in Nature Communications.
Mario Shields, PhD, research assistant professor of Medicine in the Division of Hematology and Oncology and a member of the Lurie Cancer Center, has received the National Cancer Institute’s (NCI) Cancer Moonshot Scholar Award.
Scientists have created a new synthetic biology approach to follow tumor cells over time, finding meaningful differences in why a cancer cell dies or survives in response to anti-cancer therapies.